ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-12454

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in OpenText™ Vertica allows Reflected XSS.

Published Mar 13, 2026 · catalog updated Jun 17, 2026 · Improper neutralization of input

Check if you run it

No confirmed exploitation is on record for CVE-2025-12454. EPSS is 0.19%. Act only if a listed version of Improper neutralization of input is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Improper neutralization of input).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.19%
Remediation
Advisory link
Affected products
cpe opentext/vertica

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in OpenText™ Vertica allows Reflected XSS. The vulnerability could lead to Reflected XSS attack of cross-site scripting in Vertica management console application.This issue affects Vertica: from 10.0 through 10.X, from 11.0 through 11.X, from 12.0 through 12.X, from 23.0 through 23.X, from 24.0 through 24.X, from 25.1.0 through 25.1.X.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe opentext/verticaversion unspecified

How to fix CVE-2025-12454

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-12454. EPSS is 0.19%. Act only if a listed version of Improper neutralization of input is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.19%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Mar 13, 2026 · NIST NVD

    Detected

    Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in OpenText™ Vertica allows Reflected XSS. The vulnerability could lead to Reflected XSS attack of cross-site scripting in Vertica management console application.This issue affects Vertica: from 10.0 through 10.X, from 11.0 through 11.X, from 12.0 through 12.X, from 23.0 through 23.X, from 24.0 throu

  2. Jun 17, 2026 · NIST NVD

    Updated

    Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in OpenText™ Vertica allows Reflected XSS. The vulnerability could lead to Reflected XSS attack of cross-site scripting in Vertica management console application.This issue affects Vertica: from 10.0 through 10.X, from 11.0 through 11.X, from 12.0 through 12.X, from 23.0 through 23.X, from 24.0 throu

Sources

  • CVE.orgVulnerability recordCVE-2025-12454

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-12454

    30-day exploitation probability 0.2%

    first.org
  • NIST NVDVulnerability recordCVE-2025-12454

    Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in OpenText™ Vertica allows Reflected XSS. The vulnerability could lead to Reflected XSS attack of cross-site scripting in Vertica management console application.This issue affects

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 16, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.